Hepatitis C

Hepatitis C is a blood-borne virus that infects the liver, where it causes significant inflammation, damage and disruption of normal liver function. According to estimates by the World Health Organization, around 3 to 4 million people worldwide are infected with hepatitis C every year.
What is Hepatitis C?

Hepatitis C infection is a liver infection caused by the Hepatitis C virus. Infection with hepatitis C may damage the liver leading to chronic infection.

Read More

Overview

Feature Articles

Latest Hepatitis C News and Research

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

Pharmacophore model helps find key protease inhibitor responsible for COVID-19

How COVID-19 highlights the uncertainty of medical testing

How COVID-19 highlights the uncertainty of medical testing

Good cholesterol helps SARS-CoV-2 enter cells

Good cholesterol helps SARS-CoV-2 enter cells

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Largest clinical trial launched to treat mild-to-moderate COVID-19 patients in Africa

Pomegranate peel extract shows potential as inhibitor of SARS-CoV-2 virus

Pomegranate peel extract shows potential as inhibitor of SARS-CoV-2 virus

Widespread COVID-19 testing may be possible with new dried blood tests

Widespread COVID-19 testing may be possible with new dried blood tests

Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2

Several hepatitis C drugs can inhibit crucial protein in SARS-CoV-2

New prediction model may make it easier to find which infants will develop NAS

New prediction model may make it easier to find which infants will develop NAS

COVID-19 treatments for people with early infection should be prioritized

COVID-19 treatments for people with early infection should be prioritized

Study: SphK2 enzyme regulates immune cell responses during viral infection

Study: SphK2 enzyme regulates immune cell responses during viral infection

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Promising new antivirals target arboviruses and SARS-CoV-2: Nodosome inhibitors

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Remdesivir metabolite GS-441524 inhibits SARS CoV-2 in mouse model, finds study

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Dietary restriction effective in reducing the odds of developing liver cancer from fatty liver

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Phase 1 trial results of gorilla adenovirus vaccine for COVID-19

Study may pave way for more effective treatment for Hepatitis C

Study may pave way for more effective treatment for Hepatitis C

Health care groups dive into property tax ballot fight, eyeing public health money

Health care groups dive into property tax ballot fight, eyeing public health money

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

WHO study finds Remdesivir and other repurposed drugs ineffective in COVID-19

Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis

Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis

Researchers receive $1.35 million grant to reduce impact of substance abuse in Appalachia

Researchers receive $1.35 million grant to reduce impact of substance abuse in Appalachia

SHEA releases updated guidance for healthcare workers with HIV, hepatitis

SHEA releases updated guidance for healthcare workers with HIV, hepatitis